300942SZSE

Announcement on Not Lowering the Conversion Price of "Yirui Convertible Bonds"

Erye Biotechnology Co., Ltd.··4 pages

✨ AI Summary

Shenzhen Yirui Biotechnology Co., Ltd. announced that it will not lower the conversion price of its convertible bonds despite meeting the conditions for adjustment. The board of directors made this decision during a meeting on June 4, 2026, considering market conditions and the company's long-term stability. The current conversion price remains at 12.87 CNY per share, and no adjustment proposals will be made for three months following the announcement.

Summary generated by AI · Always verify with source document

Full Translation

AI Translation· azure_openai

Shenzhen Yirui Biotechnology Co., Ltd. announces that the company and all members of the board of directors guarantee that the information disclosed is true, accurate, and complete, without false records, misleading statements, or significant omissions.

Special Reminder:

  1. As of June 4, 2026, the stock of Shenzhen Yirui Biotechnology Co., Ltd. has experienced a situation where the closing price was below 85% of the current conversion price on fifteen trading days within any consecutive thirty trading days, triggering the conditions for lowering the conversion price of "Yirui Convertible Bonds."
  2. On June 4, 2026, the company held the sixteenth meeting of the third board of directors, which reviewed and approved the proposal on not lowering the conversion price of "Yirui Convertible Bonds." The board decided not to lower the conversion price at this time, and for the next three months (from June 5, 2026, to September 4, 2026), if the conditions for lowering the conversion price are triggered again, no proposal for adjustment will be made. Starting from September 7, 2026, if the conditions for lowering the conversion price are triggered again, the board will reconsider whether to exercise the right to lower the conversion price of "Yirui Convertible Bonds."

I. Basic Information on Convertible Bonds

(1) Issuance of Convertible Bonds

With the approval of the China Securities Regulatory Commission regarding the registration of Shenzhen Yirui Biotechnology Co., Ltd. to issue convertible corporate bonds to unspecified objects (Zheng Jian Xu Ke [2023] No. 1447), the company issued 3,281,967 convertible corporate bonds on August 18, 2023, with a face value of 100.00 CNY each, totaling 328,196,700 CNY, with a term of six years.

(2) Listing of Convertible Bonds

With the approval of the Shenzhen Stock Exchange, these convertible corporate bonds have been listed and traded on the Shenzhen Stock Exchange since September 6, 2023, under the name "Yirui Convertible Bonds" and the bond code "123220."

(3) Conversion Period of Convertible Bonds

The conversion period for the issued convertible bonds is from the first trading day after six months from the end of the issuance until the maturity date of the convertible bonds, specifically from February 26, 2024, to August 17, 2029.

Sign in to read the full translation

Free accounts get 10 full releases per month. Pro subscribers get unlimited access.